German biotech startup Kynda, specializing in mycoprotein development, successfully secured EUR 3 million in Seed funding led by EnjoyVenture, with participation from the PHW Group and Clima Now.

Information on the Target

Kynda, a German biotech startup founded in 2019 by Daniel MacGowan and Franziskus Schnabel, specializes in the development of innovative mycoproteins. The company transforms food industry byproducts through fermentation to create a protein-rich and fiber-rich ingredient suitable for both food and animal feed. Kynda leverages mycelium, the root-like network of fungi, to innovate within the alternative protein space.

Recently, Kynda successfully completed its Seed funding round, which amounted to EUR 3 million. This funding round was led by EnjoyVenture, with participation from the PHW Group and Clima Now, highlighting Kynda's growing importance in the field of sustainable protein sources.

Industry Overview in Germany

The German biotech industry is known for its cutting-edge innovation and strong regulatory framework that supports research and development. It is vital for driving advancements in various sectors such as pha